6373-47-3 Usage
General Description
2-(benzyloxy)-5-chlorobenzenamine is a chemical compound that consists of a benzene ring with a chlorine atom in the 5-position and an attached benzyloxy group in the 2-position. 2-(benzyloxy)-5-chlorobenzenamine is commonly used in organic synthesis and pharmaceutical research due to its potential as a building block for the creation of various organic compounds. It is also known for its potential pharmacological properties and is being studied for its potential use in the development of new drugs. Additionally, 2-(benzyloxy)-5-chlorobenzenamine is considered to be a hazardous material and should be handled with caution and in compliance with proper safety protocols.
Check Digit Verification of cas no
The CAS Registry Mumber 6373-47-3 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 6,3,7 and 3 respectively; the second part has 2 digits, 4 and 7 respectively.
Calculate Digit Verification of CAS Registry Number 6373-47:
(6*6)+(5*3)+(4*7)+(3*3)+(2*4)+(1*7)=103
103 % 10 = 3
So 6373-47-3 is a valid CAS Registry Number.
InChI:InChI=1/C16H14N4O2S/c1-22-13-9-5-8-12(10-13)17-15(21)18-16-20-19-14(23-16)11-6-3-2-4-7-11/h2-10H,1H3,(H2,17,18,20,21)
6373-47-3Relevant articles and documents
Discovery of a Potent Botulinum Neurotoxin A Inhibitor ZM299 with Effective Protections in Botulism Mice
Gao, Jie,He, Zhili,Hong, Zhanying,Li, Tao,Luo, Deyan,Miao, Zhenyuan,Ning, Nianzhi,Wang, Hui,Wang, Jianxin,Wu, Yuelin,Xv, Xiguo,Zhang, Wannian,Zhang, Yanming,Zhuang, Chunlin
, p. 357 - 364 (2021/12/24)
Botulinum neurotoxins serotype A (BoNT/A) is the deadliest toxins known to humans and the "Category A" agent for bioterrorism. Over the past 20 years, significant efforts have been put forth to develop effective inhibitors of BoNT/A. Unfortunately, few id
BENZOFURAN-2-SULFONAMIDES DERIVATIVES AS CHEMOKINE RECEPTOR MODULATORS
-
, (2013/09/12)
The present invention relates to novel benzofuran-2-sulfonamide derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals as modulators of chemokine receptors.
HETEROCYCLYL COMPOUNDS
-
Page/Page column 31-32, (2010/02/11)
Compounds of formula (I) or a pharmaceutically acceptable derivative thereof: wherein A, B, D, Z, R1, R2a , R2b, and Rx are as defined in the specification, a process for the preparation of such compounds, pharm